There is no hazardous surcharge associated with this product.
There is no packaging charge associated with this product.
For Research Purposes only. Not for Personal use.
All compounds supplied are strictly intended for laboratory, research, analytical, and scientific use only. They are not meant for human consumption, therapeutic use, or any form of clinical application.
Bjorge, J., et al.: J. Biol. Chem., 275, 41439 (2000); Frame, M., et al.: Biochim. Biophys. Acta, 1602, 114 (2002); Frame, M., et al.: J. Cell Sci., 117, 989 (2004); Ishizawar, R., et al.: Cancer Cell, 6, 209 (2004); Diaz, N., et al.: Clin. Cancer Res., 12, 20 (2006);
Bosutinib-d3 is a deuterium labelled Bosutinib (B676095), which is a novel Src kinase inhibitor, suppresses migration and invasion of human breast cancer cells. It is a COVID19-related research product.
Hazard Compound
Refer MSDS for complete information.
Overview
Bosutinib-d3 is a deuterium labelled Bosutinib (B676095), which is a novel Src kinase inhibitor, suppresses migration and invasion of human breast cancer cells. It is a COVID19-related research product.
